Literature DB >> 10852288

Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis.

A G Fam1, B Perez-Ordonez, K Imrie.   

Abstract

A patient with rheumatoid arthritis developed a reversible, primary cutaneous, large B cell lymphoma during prolonged methotrexate (MTX) treatment. Regression of the skin lesions after discontinuation of the drug suggested a close relationship to MTX. Increased clinical awareness, discontinuation of MTX, and close observation are important in the initial management of this rare lymphoproliferative disorder.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10852288

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  4 in total

Review 1.  Multiple haematological malignancies in a patient with rheumatoid arthritis without exposure to disease modifying therapy.

Authors:  H Piper; D Mulherin; N Hardwick
Journal:  Ann Rheum Dis       Date:  2006-02       Impact factor: 19.103

2.  Cholangiocarcinoma, renal cell carcinoma and parathyroid adenoma found synchronously in a patient on long-term methotrexate.

Authors:  B F Levy; A Nisar; N D Karanjia
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 3.  Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature.

Authors:  Rita Rizzi; Paola Curci; Mario Delia; Erminia Rinaldi; Antonia Chiefa; Giorgina Specchia; Vincenzo Liso
Journal:  Med Oncol       Date:  2008-05-07       Impact factor: 3.064

Review 4.  Cutaneous primary B-cell lymphomas: from diagnosis to treatment.

Authors:  Margarida Lima
Journal:  An Bras Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.896
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.